{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:43:50Z","timestamp":1770500630251,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1999,4,9]],"date-time":"1999-04-09T00:00:00Z","timestamp":923616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1038\/sj.bjc.6690369","type":"journal-article","created":{"date-parts":[[2002,9,23]],"date-time":"2002-09-23T16:32:04Z","timestamp":1032798724000},"page":"396-402","source":"Crossref","is-referenced-by-count":109,"title":["Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer"],"prefix":"10.1038","volume":"80","author":[{"given":"N","family":"Thatcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E S De","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D R","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W P","family":"Steward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Morant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J F","family":"Vansteenkiste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-B","family":"Ewers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Sundal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Schatzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,4,9]]},"reference":[{"key":"BF6690369_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0959-8049(05)80281-3","volume":"29A","author":"R Abels","year":"1993","unstructured":"Abels, R. (1993). Erythropoietin for anaemia in cancer patients. Eur J Cancer 29A: S2\u20138.","journal-title":"Eur J Cancer"},{"key":"BF6690369_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2141.1987.tb01344.x","volume":"66","author":"AN Baer","year":"1987","unstructured":"Baer, A. N., Dessypris, E., Goldwasser, E. & Krantz, S. B. (1987). Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 66: 559\u2013564.","journal-title":"Br J Haematol"},{"key":"BF6690369_CR3","first-page":"371","volume":"118","author":"N Blumberg","year":"1994","unstructured":"Blumberg, N. & Heal, J. M. (1994). Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 118: 371\u2013379.","journal-title":"Arch Pathol Lab Med"},{"key":"BF6690369_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0305-7372(85)90027-1","volume":"12","author":"R Canetta","year":"1985","unstructured":"Canetta, R., Rosencweig, M. & Carter, S. K. (1985). Carboplatin: the clinical spectrum to date. Cancer Treat Rev 12: 125\u2013136.","journal-title":"Cancer Treat Rev"},{"key":"BF6690369_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/bjc.1993.27","volume":"67","author":"S Cascinu","year":"1993","unstructured":"Cascinu, S., Fedeli, A., Fedeli, S. L. & Catalano, G. (1993). Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study. Br J Cancer 67: 156\u2013158.","journal-title":"Br J Cancer"},{"key":"BF6690369_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/jnci\/85.10.801","volume":"85","author":"DC Case","year":"1993","unstructured":"Case, D. C., Bukowski, R. M., Carey, R. W., Fishkin, E. H., Henry, D. H., Jacobson, R. J., Jones, S. E., Keuer, A. M., Kugler, J. W., Nichols, C. R., Salmon, S. E., Silver, R. T., Storniolo, A. M., Wampler, G. L., Dooley, C. M., Larholt, K. M., Nelson, R. A. & Abels, R. I. (1993). Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85: 801\u2013806.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690369_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1200\/JCO.1995.13.7.1623","volume":"13","author":"E de Campos","year":"1995","unstructured":"de Campos, E., Radford, J., Steward, W., Milroy, R., Dougal, M., Swinden, R., Testa, N. & Thatcher, N. (1995). Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small cell lung cancer. J Clin Oncol 13: 1623\u20131631.","journal-title":"J Clin Oncol"},{"key":"BF6690369_CR8","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1200\/JCO.1997.15.7.2715","volume":"15","author":"L Del Mastro","year":"1997","unstructured":"Del Mastro, L., Venturini, M., Lionetto, R., Garrone, O., Melioli, G., Pasquetti, W., Sertoli, M. R., Bertelli, G., Canavese, G., Constantini, M. & Rosso, R. (1997). Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol 15: 2715\u20132721.","journal-title":"J Clin Oncol"},{"key":"BF6690369_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM198701083160203","volume":"316","author":"JW Eschbach","year":"1978","unstructured":"Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K. & Adamson, J. W. (1978). Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316: 73\u201378.","journal-title":"N Engl J Med"},{"key":"BF6690369_CR10","first-page":"1779","volume":"10","author":"V Gebbia","year":"1990","unstructured":"Gebbia, V., Valenza, R. & Rausa, L. (1990). The in vitro effect of recombinant erythropoietin on cisdiamminodichloroplatinum-induced inhibition of murine erythroid stem cells. Anticancer Res 10: 1779\u20131782.","journal-title":"Anticancer Res"},{"key":"BF6690369_CR11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","volume":"15","author":"J Glaspy","year":"1997","unstructured":"Glaspy, J., Bukowski, R., Steinberg, D., Taylor, C., Tchekmedyian, S. & Vadhan-Raj, S. (1997). Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice Procrit Study Group. J Clin Oncol 15: 1218\u20131234.","journal-title":"J Clin Oncol"},{"key":"BF6690369_CR12","first-page":"6a","volume":"74","author":"DH Henry","year":"1989","unstructured":"Henry, D. H., Rudnick, S. A., Bryant, E., Adels, R. I., Danna, R. P., Staddon, A. P. & Mason, B. A. (1989). Preliminary report of two double-blind, placebo-controlled studies using human recombinant erythropoietin (r-HuEPO) in the anemia associated with cancer. Blood 74: 6a","journal-title":"Blood"},{"key":"BF6690369_CR13","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/1097-0142(19881015)62:8<1466::AID-CNCR2820620803>3.0.CO;2-#","volume":"62","author":"PJ Hesketh","year":"1988","unstructured":"Hesketh, P. J., Cooley, T. P., Finkel, H. E., Wright, J. & Hesketh, A. M. (1988). Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil and mitomycin C. Cancer 62: 1466\u20131470.","journal-title":"Cancer"},{"key":"BF6690369_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0140-6736(92)91404-V","volume":"340","author":"SB Kaye","year":"1992","unstructured":"Kaye, S. B., Lewis, C. R., Paul, J., Duncan, I. D., Gordon, H. K., Kitchener, H. C., Cruickshank, D. J., Atkinson, R. J., Soukop, M., Rankin, E. M., Cassidy, J., Davis, J. A., Reed, N. S., Crawford, S. M., MacLean, A., Swapp, G. A., Sarkar, T. K., Kennedy, J. H. & Symonds, R. P. (1992). Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer. Lancet 340: 329\u2013333.","journal-title":"Lancet"},{"key":"BF6690369_CR15","first-page":"110","volume":"303","author":"ME Kuzur","year":"1980","unstructured":"Kuzur, M. E. & Greco, F. A. (1980). Cisplatin-induced anemia. N Engl J Med 303: 110\u2013111.","journal-title":"N Engl J Med"},{"key":"BF6690369_CR16","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJM199006143222402","volume":"322","author":"H Ludwig","year":"1990","unstructured":"Ludwig, H., Fritz, E., Kotzmann, H., Hocker, P., Gisslinger, H. & Barnas, U. (1990). Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322: 1693\u20131699.","journal-title":"N Engl J Med"},{"key":"BF6690369_CR17","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0959-8049(05)80282-5","volume":"29A","author":"H Ludwig","year":"1993","unstructured":"Ludwig, H., Leitgeb, C., Fritz, E., Krainer, M., Kuhrer, I., Kornek, G., Sagaster, P. & Weissmann, A. (1993a). Erythropoietin treatment of chronic anaemia of cancer. Eur J Cancer 29A: S8\u201312.","journal-title":"Eur J Cancer"},{"key":"BF6690369_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/stem.5530110502","volume":"11","author":"H Ludwig","year":"1993","unstructured":"Ludwig, H., Pecherstorfer, M., Leitgeb, C. & Fritz, E. (1993b). Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma. Stem Cells 11: 348\u2013355.","journal-title":"Stem Cells"},{"key":"BF6690369_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller, A. B., Hoogstraten, B., Staquet, M. & Winkler, A. (1981). Reporting results of cancer treatment. Cancer 47: 207\u2013214.","journal-title":"Cancer"},{"key":"BF6690369_CR20","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1056\/NEJM199006143222401","volume":"322","author":"CB Miller","year":"1990","unstructured":"Miller, C. B., Jones, R. J., Piantadosi, S., Abeloff, M. D. & Spivak, J. L. (1990). Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322: 1689\u20131692.","journal-title":"N Engl J Med"},{"key":"BF6690369_CR21","first-page":"129","volume-title":"Erythropoietin: Molecular Physiology and Clinical Applications","author":"J Radermacher","year":"1993","unstructured":"Radermacher, J. & Koch, K. M. (1993). Erythropoietin and hypertension. In Erythropoietin: Molecular Physiology and Clinical Applications, Bauer C, Koch KM, Scigella P, et al (eds), pp. 129\u2013152. Marcel Dekker: New York"},{"key":"BF6690369_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/stem.5530030607","volume":"3","author":"SA Rothmann","year":"1985","unstructured":"Rothmann, S. A., Paul, P., Weick, J. K., McIntyre, W. R. & Fantelli, F. (1985). Effect of cis-diamminedichloroplatinum on erythropoietin production and hematopoietic progenitor cells. Int J Cell Cloning 3: 415\u2013423.","journal-title":"Int J Cell Cloning"},{"key":"BF6690369_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00000421-199302000-00006","volume":"16","author":"JR Skillings","year":"1993","unstructured":"Skillings, J. R., Sridhar, F. G., Wong, C. & Paddock, L. (1993). The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study. Am J Clin Oncol 16: 22\u201325.","journal-title":"Am J Clin Oncol"},{"key":"BF6690369_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ajcp\/88.3.374","volume":"88","author":"RH Walker","year":"1987","unstructured":"Walker, R. H. (1987). Special report: transfusion risks. Am J Clin Pathol 88: 374\u2013378.","journal-title":"Am J Clin Pathol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:52:53Z","timestamp":1684414373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4,9]]},"references-count":24,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["BF6690369"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690369","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4,9]]}}}